1.126 - 1.150 of 32.999
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Salesforce Call 220,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 4,73x
- Analysis
- Allianz Call 440,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 19,87x
- Analysis
- Moderna Call 35,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,34x
- Analysis
- R3NK GY Call 62,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 3,98x
- Analysis
- Moderna Call 25,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 3,44x
- Analysis
- Zscaler, Inc. Call 250,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 5,10x
- Analysis
- HAG GY Call 130,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 7,92x
- Analysis
- Novo Nordisk Call 250,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 2,83x
- Analysis
- Novo Nordisk Call 280,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 5,42x
- Analysis
- Palantir Technologies Call 300,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,34x
- Analysis
- Swiss Life Holding Call 1.500,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 7,08x
- Analysis
- Swiss Life Holding Call 1.500,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 7,05x
- Analysis
- Adidas Call 140,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,12x
- Analysis
- Palantir Technologies Call 300,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 2,39x
- Analysis
- Novo Nordisk Call 240,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 2,61x
- Analysis
- Arista Networks Call 220,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,33x
- Analysis
- Palantir Technologies Call 300,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 10,23x
- Analysis
- Palantir Technologies Call 300,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 2,73x
- Analysis
- Novo Nordisk Call 320,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 2,83x
- Analysis
- Palantir Technologies Call 300,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 3,11x
- Analysis
- Commerzbank Call 55,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 7,12x
- Analysis
- RATIONAL Call 600,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,70x
- Analysis
- Zalando SE Call 20,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,05x
- Analysis
- Eli Lilly Call 700,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 2,70x
- Analysis
- Novo Nordisk Call 440,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,85x
- Analysis